Idexx revenues up 10%; co. addresses FTC concerns

Westbrook-based biotechnology firm Idexx on Friday said its revenues increased 10% for the first quarter of the year. The company also announced changes to its product distribution to address concerns raised by the Federal Trade Commission.
The company’s revenues for Q1 2012 were $322.7 million, up from $292.7 million the same quarter in 2011, according to a press release. Gross profit increased 13% to $174.8 million, and net income grew to ...